CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
Holding CNBX?
Track your performance easily

CNBX Pharmaceuticals (CNBX) Income Statement

120 Followers

CNBX Pharmaceuticals Income Statement

Last quarter (Q ), CNBX Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, CNBX Pharmaceuticals's net income was $-130.63K. See CNBX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Aug 23Aug 22Aug 21Aug 20Aug 19
Total Revenue
$ 230.07K$ 410.17K$ 29.96K-$ 7.16K$ 9.84K
Cost of Revenue
$ 6.22K-----
Gross Profit
$ 223.85K$ 410.17K$ 29.96K-$ 7.16K$ 9.84K
Operating Expense
$ 915.96K$ 1.34M$ 2.98M$ 2.60M$ 3.05M$ -3.31M
Operating Income
$ -692.10K$ -931.38K$ -2.95M$ -2.60M$ -3.04M$ -3.30M
Net Non Operating Interest Income Expense
$ -12.63K$ -1.17K$ -1.27K$ -2.39K$ -8.13K$ 18.35K
Other Income Expense
$ -43.83K$ -52.62K$ -1.44M$ -594.27K$ 4.42M$ -4.44M
Pretax Income
$ -700.90K$ -931.38K$ -4.39M$ 126.51K$ -7.47M$ 1.13M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -1.21M$ -3.71M$ -4.39M$ -3.19M$ -7.47M$ 1.13M
Basic EPS
$ -0.04$ -0.42$ -3.59$ -2.40$ -12.00-
Diluted EPS
$ -0.04$ -0.42$ -3.59$ -2.40$ -12.00$ 2.40
Basic Average Shares
$ 112.67M$ 8.82M$ 1.22M$ 1.15M$ 1.12M$ 1.10M
Diluted Average Shares
$ 112.67M$ 8.82M$ 1.22M$ 1.15M$ 1.12M$ 472.07K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 922.18K$ 1.34M$ 2.98M$ 2.60M$ 3.05M$ -3.31M
Net Income From Continuing And Discontinued Operation
$ -1.21M$ -3.71M$ -4.39M$ -3.19M$ -7.47M$ 1.13M
Normalized Income
$ -506.78K$ -586.68K-$ 587.30K--
Interest Expense
------
EBIT
$ -692.96K$ -930.21K$ -4.39M$ 128.90K$ -7.46M$ 1.11M
EBITDA
$ -582.14K$ -768.14K$ -4.19M$ 349.83K$ -7.24M$ 1.30M
Currency in USD

CNBX Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis